Insight

Chiara Corti: Our ASCO Daily News editorial “IMpassion132”

Chiara Corti/LinkedIn

Aug 19, 2024, 06:51

Chiara Corti: Our ASCO Daily News editorial “IMpassion132”

Chiara Corti shared a post on LinkedIn:

“Check out our American Society of Clinical Oncology (ASCO) Daily News editorial ‘IMpassion132: Learning From Immunotherapy’s Failures in Early Relapsing Triple-Negative Breast Cancer’. ”

Source: Chiara Corti/LinkedIn

More posts by Chiara Corti in OncoDaily.

Chiara Corti is currently a Clinical Research Fellow at Dana-Farber Cancer Institute in Boston, focusing on early drug development for patients with solid tumors, with a special commitment to breast cancer. Since November 2019, she has also been a Medical Oncology Fellow at the European Institute of Oncology (IEO).

American Society of Clinical Oncology ASCO ASCO Daily News cancer Chiara Corti Dana-Farber Cancer Institute immunotherapy IMpassion132 OncoDaily Oncology triple-negative breast cancer

Esophageal Cancer: Symptoms, Causes, Stages, Diagnosis & Treatment

Faster, Flexible and Affordable: Mikhail Groubman on Building a Global Legacy in Clinical Research in an Untapped Market

Invest in Health Policy: A Conversation with Professor Andreas Charalambous

FDA Approves Cosibelimab-ipdl for Treatment of Metastatic or Locally Advanced Cutaneous Squamous Cell Carcinoma

Dolph Lundgren’s Fight for Life: How He Survived Kidney Cancer After 9 Years of Battle

Special Coverage